U.S. Pharma Stock News

NasdaqGS:GIII
NasdaqGS:GIIILuxury

Does Legal Tensions With PVH And Governance Scrutiny Change The Bull Case For G-III (GIII)?

In recent months, G-III Apparel Group reported fiscal 2026 net sales of US$3.00 billion, reduced from US$3.20 billion a year earlier, while facing weaker guidance, a 33% cut to CEO Morris Goldfarb’s estimated 2026 pay, and intensified legal conflict with PVH Corp. over key brand licenses. At the same time, the company is emphasizing its strong balance sheet, over US$400 million in cash, new quarterly dividend, and a push into owned brands like DKNY and Donna Karan, even as insider share...
NYSE:STVN
NYSE:STVNLife Sciences

Stevanato Group (NYSE:STVN) Margin Uptick Tests Bullish Earnings Narrative After Q1 2026 Results

Stevanato Group (NYSE:STVN) opened 2026 with Q1 revenue of €273.6 million and basic EPS of €0.10, alongside trailing 12 month revenue of about €1.2 billion and EPS of €0.52 that frame the latest quarter against a fuller earnings backdrop. Over recent periods, revenue has ranged from €256.6 million in Q1 2025 to €346.5 million in Q4 2025, while basic EPS has moved between €0.10 and €0.17 across those quarters, giving investors a clear view of how the top and bottom lines are tracking into the...
NYSE:VSH
NYSE:VSHElectronic

Vishay’s New Proximity Sensor Highlights Growth Potential But Valuation Concerns

Vishay Intertechnology (NYSE:VSH) has introduced the VCNL36758, a high sensitivity proximity sensor targeting smart home, industrial, and office uses. The device integrates an IR emitter, photodiode, amplifier, and ADC in a compact package to support presence detection, automation, and energy management applications. The launch highlights a new product focused on saving board space while broadening detection capabilities for next generation electronics. For investors tracking NYSE:VSH, this...
NYSE:CW
NYSE:CWAerospace & Defense

Curtiss Wright (CW) Margin Improvement To 14.2% Tests Premium Valuation Narratives

Curtiss-Wright (CW) opened 2026 with Q1 revenue of US$913.7 million and Basic EPS of US$3.47, while trailing twelve month revenue sat at about US$3.6 billion with EPS of US$13.73 and net income of US$511.1 million. Over the last five reported quarters, revenue has moved from US$805.6 million in Q1 2025 to US$913.7 million in Q1 2026, with Basic EPS over that span ranging between US$2.69 and US$3.71. With trailing net profit margin edging higher over the past year, these results give investors...
NYSE:PRI
NYSE:PRIInsurance

Primerica (PRI) Combined Ratio Of 65.2% Tests Bullish Profitability Narratives

Primerica (PRI) opened 2026 with Q1 revenue of US$885.9 million and basic EPS of US$6.00, supported by net income of US$190.1 million and a combined ratio of 65.2%, setting a clear tone for how the year is starting. The company has seen quarterly revenue move from US$803.4 million in Q4 2024 to US$819.5 million in Q1 2025 and then to US$885.9 million in Q1 2026. Over that period, basic EPS ranged from US$4.99 to US$6.36, pointing to a business that is still generating meaningful profits as...
NYSE:MWA
NYSE:MWAMachinery

Mueller Water Products Shifts Capital Toward Acquisitions To Expand Footprint

Mueller Water Products (NYSE:MWA) has flagged a higher priority on acquisitions, with management highlighting more active work on potential targets. The company is planning to use its balance sheet and increased M&A readiness to expand its portfolio and support net sales growth. This marks a shift in capital allocation focus toward deals that could reshape its market presence and operating profile. Mueller Water Products focuses on water infrastructure products and services, an area that...
NYSE:CB
NYSE:CBInsurance

Chubb Alliance With Verified Clinical Trials And What It May Mean For CB

Chubb (NYSE:CB) has formed an alliance with Verified Clinical Trials to support risk management and data quality in clinical research. The partnership focuses on research subject safety, data integrity, and reducing operational and regulatory risks using VCT's subject registry technology. This development extends Chubb's activity beyond traditional insurance coverage into technology driven clinical trial risk solutions. For investors tracking Chubb at a current share price of $321.28, the...
NYSE:ETR
NYSE:ETRElectric Utilities

Is It Too Late To Consider Entergy (ETR) After Its Strong Multi Year Rally?

If you are wondering whether Entergy stock still offers value at recent prices, it helps to step back and look at both the recent returns and what they might be pricing in. The stock last closed at US$112.02, with a 7 day return of a 5% decline, a 30 day return of a 1.6% decline, and a gain of 19.3% year to date and 37.9% over the past year, with multi year returns that have been very large over 3 and 5 years. Recent price moves sit against a backdrop of ongoing interest in regulated...
NasdaqGM:NTLA
NasdaqGM:NTLABiotechs

Is Intellia Therapeutics (NTLA) Pricing Reflect Its Gene Editing Potential After Recent Price Surge

Wondering if Intellia Therapeutics at around US$13.71 is offering value or just volatility? This article walks through what the current price may be implying about the stock. The stock has returned 1.7% over the last 7 days, 1.2% over 30 days, 48.9% year to date and 65.6% over the past year, while longer term 3 year and 5 year returns of 69.3% and 77.5% declines show how sentiment around the stock has shifted over time. Recent headlines around Intellia Therapeutics have focused on its...
NasdaqCM:AHCO
NasdaqCM:AHCOHealthcare

AdaptHealth (AHCO) Boosts 2026 Outlook and Refinances Debt Is Its Growth Strategy Evolving?

In early May 2026, AdaptHealth Corp. reported first-quarter net revenue of US$819.8 million, a wider net loss of US$16.04 million, completed a US$1.10 billion refinancing of its senior secured credit facility, and raised its 2026 net revenue guidance to US$3.45 billion–US$3.52 billion. Management highlighted that the stronger balance sheet will support disciplined tuck-in acquisitions in core Sleep and Respiratory Health, alongside a large de novo expansion and an advanced digital patient...
NasdaqGS:CHYM
NasdaqGS:CHYMDiversified Financial

Chime Financial Q1 Profit Of US$53.5m Tests Bearish Earnings Narratives

Q1 2026 results reset the earnings picture for Chime Financial (CHYM) Chime Financial (CHYM) opened 2026 with Q1 revenue of US$647.4 million and basic EPS of US$0.14, alongside net income of US$53.5 million. The trailing twelve months still show a net loss of US$956.5 million and basic EPS of US$3.03 loss. Over recent quarters, the company has seen revenue move from US$475.2 million in Q4 2024 to US$518.7 million in Q1 2025, US$528.1 million in Q2 2025, US$543.5 million in Q3 2025, US$596.4...
NYSE:UDR
NYSE:UDRResidential REITs

UDR Shifts To Monthly Dividends And Expands Buybacks For Investors

UDR (NYSE:UDR) has shifted to monthly dividend payments, becoming the first major apartment REIT to use this payout schedule. The company paired the change in dividend frequency with an expansion of its share repurchase program. These moves followed Q1 results that were described as better than expected. UDR focuses on owning and operating multifamily apartment communities, a segment that often attracts income focused investors looking for regular cash flow from real estate. The switch to...
NasdaqGS:OLED
NasdaqGS:OLEDSemiconductor

Universal Display And SFC Partnership Targets Future OLED Efficiency And Returns

Universal Display (NasdaqGS:OLED) and SFC Co. Ltd. agreed to co-develop and commercialize highly efficient phosphorescent OLED material systems. The partnership focuses on materials for next generation display and lighting applications, targeting energy efficiency and performance improvements. The collaboration is positioned as part of Universal Display's broader effort to expand its OLED materials ecosystem. Universal Display, best known for its OLED materials and IP portfolio, sits at the...
NYSE:DKL
NYSE:DKLOil and Gas

Delek Logistics Refinancing Shift Resets Debt Costs And Maturity Profile

Delek Logistics Partners (NYSE:DKL) has launched US$800 million in new senior notes due 2034. The partnership has also started a cash tender offer for its existing 2028 senior notes. The refinancing is intended to adjust its debt profile by using proceeds from the 2034 notes to address higher coupon 2028 and 2029 notes. For you as an investor, this refinancing move goes straight to the core of how Delek Logistics Partners, a midstream operator, finances its business. Adjusting maturities...
NYSE:UWMC
NYSE:UWMCDiversified Financial

Should UWM’s Return to Profitability and In-House Servicing Push Require Action From UWM Holdings (UWMC) Investors?

UWM Holdings Corporation recently reported first-quarter 2026 results, swinging to a net income of US$25.3 million from a net loss of US$13.68 million a year earlier, and affirmed a quarterly dividend of US$0.10 per share payable on July 9, 2026. Management linked the return to profitability to higher mortgage origination volumes and outlined a move to bring all loan servicing in-house by year-end to improve efficiency and client experience. We’ll now explore how UWM’s return to...
NasdaqGS:KLIC
NasdaqGS:KLICSemiconductor

Kulicke And Soffa (KLIC) Q2 EPS Rebound Tests Bearish Earnings Volatility Narrative

Kulicke and Soffa Industries (KLIC) has just turned in a punchy Q2 2026 scorecard, with revenue of US$242.6 million and basic EPS of US$0.67, alongside trailing 12 month EPS of US$1.05 on revenue of US$768.2 million. Over the past few quarters the company has seen revenue move from US$161.9 million in Q2 2025 to US$148.4 million in Q3 2025, US$177.6 million in Q4 2025, US$199.6 million in Q1 2026 and now US$242.6 million in Q2 2026. Quarterly EPS ranged from a loss of US$1.59 in Q2 2025 to...
NYSE:MRSH
NYSE:MRSHInsurance

Marsh And McLennan’s Formula 1 Deal Puts Risk Story In Focus

Marsh, a business of Marsh & McLennan Companies, has entered a multi year global partnership with Formula 1. Marsh becomes Formula 1's first Official Risk Partner and Insurance Brokering Partner under this agreement. The partnership positions Marsh & McLennan (NYSE:MRSH) alongside one of the most widely followed global sports properties. For investors watching Marsh & McLennan at a current share price of $166.03, this Formula 1 tie up comes after a mixed share performance picture. The stock...
NYSE:TPH
NYSE:TPHConsumer Durables

A Look At Tri Pointe Homes (TPH) Valuation After Strong Recent Returns And Full Pricing To Analyst Targets

What Tri Pointe Homes’ Recent Returns Tell You Tri Pointe Homes (TPH) has drawn attention after a past 3 months total return of 32.4% and year to date return of 48.7%. These figures are prompting investors to reassess the stock’s recent momentum and underlying fundamentals. See our latest analysis for Tri Pointe Homes. Tri Pointe Homes’ recent share price return over 90 days of 32.4% and year to date share price return of 48.7%, alongside a 5 year total shareholder return of 93.37%, points to...
NYSE:SJM
NYSE:SJMFood

Is It Time To Reassess J. M. Smucker (SJM) After Its Recent Share Price Weakness

If you are wondering whether J. M. Smucker at around US$99 a share looks cheap, expensive, or somewhere in between, the starting point is understanding how its current price lines up against different measures of value. The stock is trading near US$99.44, with recent returns of 1.4% over 7 days, 5.6% over 30 days and 2.9% year to date. Over the last year the return sits at a 7.7% decline, and the 3 and 5 year returns are 29.9% and 14.3% declines respectively. These figures can affect how...
NasdaqGS:CME
NasdaqGS:CMECapital Markets

CME Group Expands Benchmarks And Crypto Futures While Valuation Signals Caution

CME Group (NasdaqGS:CME) introduced the U.S. dollar RepoFunds Rate (RFR USD) this week as a new overnight repo market benchmark. The company also listed Avalanche (AVAX) and Sui (SUI) cryptocurrency futures, expanding its regulated crypto derivatives suite. These launches extend CME Group's reach in both fixed income market infrastructure and institutional crypto trading. CME Group, known for its global derivatives exchanges, is leaning further into rate benchmarks and digital assets as...